Radiation dose rates from adult patients undergoing nuclear medicine investigations.
Adult patients undergoing nuclear medicine investigations may subsequently come into close contact with members of the public and hospital staff. In order to expand the available dosimetry and derive appropriate recommendations, dose rates were measured at 0.1, 0.5 and 1.0 m from 80 adult patients just before they left the nuclear medicine department after undergoing one of eight 99Tcm studies, an 123I thyroid, an 111In leucocyte or a 201Tl cardiac scan. The maximum departure dose rates at these distances of 150, 30 and 7.3 microSv h-1 were greater than those found in similar published studies of adult and paediatric patients. To limit the dose to an infant to less than 1 mSv, an 111In leucocyte scan is the only investigation for which it may be necessary to restrict close contact between the infant and a radioactive parent, depending on the dose rate near the surface of the patient, the parent's habits and how fretful is the infant. It is unlikely that a ward nurse will receive a dose of 60 microSv in a working day if caring for just one radioactive adult patient, unless the patient is classified as totally helpless and has undergone a 99Tcm marrow, bone or brain scan. The data and revised calculations of effective exposure times based on a total close contact time of 9 h in every 24 h period should allow worst case estimates of radiation dose to be made and recommendations to be formulated for other circumstances, including any future legislative changes in dose limits or derived levels.
Mountford
P J
PJ
Department of Nuclear Medicine, Kent and Canterbury Hospital, UK.
O'Doherty
M J
MJ
Forge
N I
NI
Jeffries
A
A
Coakley
A J
AJ
D000328:Adult; D006801:Humans; D007205:Indium Radioisotopes / Q000009:adverse effects; D007457:Iodine Radioisotopes / Q000009:adverse effects; D009683:Nuclear Medicine; D015609:Organotechnetium Compounds / Q000009:adverse effects; D010290:Parents; D010564:Personnel, Hospital; D011829:Radiation Dosage; D011834:Radiation Monitoring; D011835:Radiation Protection; D011877:Radionuclide Imaging / Q000009:adverse effects*; D013794:Thallium Radioisotopes / Q000009:adverse effects
D007205:Indium Radioisotopes; D007457:Iodine Radioisotopes; D015609:Organotechnetium Compounds; D013794:Thallium Radioisotopes